December 5, 2025 · Form 4 insider transaction
Cambrian BioPharma Inc sold 1,745 shares of SNSE at $12.29 per share, a transaction worth $21.4K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 3 days after the transaction.
The price reported in Column 4 is a weighted average price. The prices sold ranged from $12.02 to $12.95. The reporting person will provide the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range.; These shares are held by Cambrian Biopharma, Inc., a Delaware corporation ("Cambrian"). The Chief Executive Officer of Cambrian, James Peyer, may direct the voting and disposition of the shares held by Cambrian, subject in certain instances to the approval of Cambrian's Board of Directors. Mr. Peyer disclaims beneficial ownership of such shares.